Vascular pleiosynergy - Does it really work?

Research output: Contribution to journalReview article

1 Citation (Scopus)

Abstract

Cardiovascular risk increases exponentially by multiple risk factors. Similarly, by simultaneously treating these risk factors the therapeutic benefit can be multiplied. It is also relevant that some drugs exert extra benefit by acting beyond their main effect. A wide range of pleiotropic effects have been reported among lipid lowering statins and third-generation calcium channel blockers. These include an increase of endothelial nitric oxide (NO) production, inhibition of free radical formation and reduction of migration and proliferation of smooth muscle cells independently from the main therapeutic effect of these drugs. Favorable "therapeutic cross effects" due to pleiotropic mechanisms can be defined as pleiosynergy.

Original languageEnglish
Pages (from-to)302-304
Number of pages3
JournalCurrent Vascular Pharmacology
Volume5
Issue number4
DOIs
Publication statusPublished - Oct 1 2007

Keywords

  • Amlodipine
  • Pleiotropic
  • Statin
  • Synergy
  • Vascular effect

ASJC Scopus subject areas

  • Pharmacology
  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Vascular pleiosynergy - Does it really work?'. Together they form a unique fingerprint.

  • Cite this